electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026

Core Insights - electroCore, Inc. will report its financial results for Q4 and the full year ended December 31, 2025, on March 19, 2026, after market close [1] - A webinar will be hosted by management at 4:30 PM EDT to review the financial results and address investor questions [2] Company Overview - electroCore, Inc. is a bioelectronic technology company focused on improving health and quality of life through innovative non-invasive bioelectronic technologies [3] - The company's leading prescription products include gammaCore, a non-invasive vagus nerve stimulation (nVNS) device, and Quell® for fibromyalgia treatment [3] - Additionally, electroCore commercializes handheld products like Truvaga and TAC-STIM nVNS, aimed at promoting general wellness and human performance [3]